HC Wainwright & Co. maintained its Chimerix [CMRX] rating to the equivalent of Buy but changed the price target to $16.0 from $7, in a research note dated 2021-01-11. That figure represents around a 90.02% premium from where the company’s shares closed on Friday. Some new analysts also started their coverage, with H.C. Wainwright’s analysts assigning the shares to “a Buy” rating in a research note to investors issued in early February. Meanwhile, FBR Capital had maintained its rating on CMRX to the earlier “Mkt perform” rating, in a research note produced for clients August 09, 2016. In addition, there was no change from FBR Capital on February 23, 2016. The rater maintained CMRX to “a Mkt perform” but assigned new target price of $10.
Is Chimerix Inc. [NASDAQ:CMRX] a Good Buy Right Now?
It should be noted that CMRX technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 88% Buy in the last week and compares with 100% Buy in the past month. Data from Chimerix Inc.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 1.37 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.91 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.67 million shares.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
CMRX Price Performance
On Wall Street, Chimerix Inc. [NASDAQ:CMRX] finished Friday’s session up 69.08% at $8.42. The stock went up to $9.36 at the same session while its lowest single day price was $6.55. In the last five days, it saw a rise of about 74.33%, Chimerix Inc. shares gained by almost 74.33% since the beginning of the year. However, the share price has dropped to as low as 52.54% below its one year high. On 01/08/21, the company shares recorded $9.36, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $4.71. The company’s shares have inclined by 291.63% in the past year. The 50-day SMA achieved is $4.14 while the 200-day SMA is $3.09. Volume gained to 20.39 million from 0.21 million in the previous session.
CMRX Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 6.86 level, and in case of violation of this particular level, it will cause more drop to 5.30 level. On the upper level, 10.92 is still the key resistance. The stock may increase to the subsequent resistance at 9.67. The Relative Strength Index (RSI) pinned on the 14-day chart is 85.29, implying a overbought technical stance while the MACD stands at 0.86, meaning price will decrease in the next trading period. Percent R indicator moved to 19.75%, implying bullish price movement. Stochastic %K at 46.32% suggest selling the stock.
What is the short interest in Chimerix Inc.?
Short interest in the Chimerix Inc. stock has surged, increasing by 58940.0 shares to total 0.88 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 0.94 million, data from Yahoo Finance shows. The decrease of -6.68% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 1.81% of the overall float for the stock.
Chimerix Inc.’s Biggest Shareholders: Who Owns Chimerix Inc. [CMRX]?
Filings by Opaleye Management, Inc. showed that the firm now holds a total of 3,841,500 shares or roughly 6.13% of the outstanding CMRX shares. This means their shares have increased by 1,736,500 from the 3,841,500 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, BlackRock Fund Advisors updated stake is worth $12,645,432. Details in the latest 13F filings reveal that Renaissance Technologies LLC disposed off their -0.42% stake valued at $11,105,625 while The Vanguard Group, Inc. cut theirs at $8,821,276. During the last quarter, Renaissance Technologies LLC liquidated -12,500 of its shares in Chimerix Inc. while The Vanguard Group, Inc. sold -2,946 shares. The Dimensional Fund Advisors LP’s holdings currently number 2,316,298 shares at $19503229.16. According to the firm’s last 13F report, Ikarian Capital LLC shares in the company at filing stood at 1,364,044 shares, roughly $5,142,446.
CMRX Earnings Forecast For The Current Quarter
Chimerix Inc. [CMRX] is expected to report weak earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $1.03M and an earnings per share of -$0.2 for Dec 2020. Looking further ahead, the company is expected to report revenue of $1.5M at an EPS of -$0.2 for Mar 2021. The estimates represent downside of 547.70% and 47.90% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
CMRX Earnings Estimates For The Current Year
For the financial year, Chimerix Inc. [NASDAQ:CMRX] is expected to bring in revenue of $5.3M. The returns are nearly $-7.22 million lower than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at -0.71, higher than that of FY19 by $1.32. Estimates put this year’s earnings growth at 65.00%, 47.90% for the next. As for sales, forecasts are for a decrease of -57.70% in the current fiscal year and a further 547.70% over the following year.